ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.

Hsiang-I Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.